Filing Details

Accession Number:
0001209191-15-066176
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-14 20:36:08
Reporting Period:
2015-08-12
Filing Date:
2015-08-14
Accepted Time:
2015-08-14 20:36:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404644 Aquinox Pharmaceuticals Inc AQXP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1600046 Kamran Alam C/O Aquinox Pharmaceuticals, Inc.
450 - 887 Great Northern Way
Vancouver A1 V5T 4T5
Cfo, Vice President Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-12 8,246 $5.76 8,246 No 4 M Direct
Common Stock Acquisiton 2015-08-12 20,833 $5.76 29,079 No 4 M Direct
Common Stock Disposition 2015-08-12 29,079 $18.67 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-08-12 8,246 $0.00 8,246 $5.76
Common Stock Stock Option (Right to Buy) Disposition 2015-08-12 20,833 $0.00 20,833 $5.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,170 2022-05-29 No 4 M Direct
0 2021-08-22 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.775 to $20.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price withinh the ranges set in this footnote.
  2. The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date.
  3. Fully vested.